Abiopharma

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025

Ionis receives U.S. FDA Breakthrough Therapy designation for ION582 in Angelman syndrome

New Form 8-K - HARVARD BIOSCIENCE INC Filed: 2025-09-09 AccNo: 0001171843-25-005787 Size: 244 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - HARROW, INC. Filed: 2025-09-09 AccNo: 0001493152-25-012840 Size: 297 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Castle Biosciences - New Data at American Foregut Societys 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions

New Form 6-K - EDAP TMS SA Filed: 2025-09-09 AccNo: 0001171843-25-005786 Size: 8 MB

New Form 6-K - GH Research PLC Filed: 2025-09-09 AccNo: 0001140361-25-034360 Size: 434 KB

ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California

Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Improvements in Survival Outcomes for Advanced Non-small Cell Lung Cancer

New Data at American Foregut Societys 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions

Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology (EADV) Congress

Breckenridge Brewery Awarded Silver Certification by the Colorado Green Business Network for Excellence in Sustainability Practices

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calciums Dose Strengths in Progressive Multiple Sclerosis